Drug Delivery Devices Market Share
ID: MRFR/HC/10320-HCR
128 Pages
October 2025
Drug Delivery Devices Market Size, Growth Research Report By Drug Delivery Route (Oral, Injectable, Transdermal, Inhalation, Implantable), By Device Type (Syringes, Pumps, Inhalers, Patch Delivery Systems, Nebulizers), By Application (Diabetes, Cancer, Cardiovascular, Autoimmune Disorders, Pain Management), By End User (Hospitals, Homecare, Pharmaceutical Companies, Research Institutions) and B...
Market Summary
As per Market Research Future Analysis, the Drug Delivery Devices Market was valued at 276.84 USD Billion in 2024 and is projected to grow to 468.65 USD Billion by 2035, with a CAGR of 4.90% from 2025 to 2035. The market is driven by the rising prevalence of chronic diseases and the demand for innovative delivery systems, particularly in home healthcare solutions. Technological advancements, including smart drug delivery systems, are enhancing patient adherence and therapeutic outcomes.
Key Market Trends & Highlights
The Drug Delivery Devices Market is experiencing significant growth influenced by various trends.
- Market Size in 2024: 276.84 USD Billion; Expected to reach 468.65 USD Billion by 2035. Oral drug delivery route valued at 15.0 USD Billion in 2024; projected to grow to 27.0 USD Billion by 2035. Injectable segment valued at 14.0 USD Billion in 2024; expected to rise to 25.0 USD Billion by 2035. North America market valued at 20.0 USD Billion in 2024; projected to increase to 36.0 USD Billion by 2035.
Market Size & Forecast
| 2024 Market Size | USD 276.84 Billion |
| 2035 Market Size | USD 468.65 Billion |
| CAGR (2025-2035) | 4.90% |
| Largest Regional Market Share in 2024 | North America |
Major Players
<p>Pfizer, Merck and Co, Sandoz, AbbVie, Roche, Eli Lilly, Boehringer Ingelheim, Johnson and Johnson, Novartis, Hikma Pharmaceuticals, Medtronic, Becton Dickinson, AstraZeneca, GlaxoSmithKline, Sanofi</p>
Market Trends
A surge in chronic diseases, an aging population, and the increasing demand for efficient and effective treatment options are all contributing to the significant growth of the Drug Delivery Devices Market. The development of advanced medication delivery systems that guarantee precise dosage and enhanced patient conformance has been required due to the increasing prevalence of conditions like cancer and diabetes. Furthermore, the emergence of smart drug delivery devices has been facilitated by technological advancements in materials and designs, which can monitor and modify medication administration in real time, thereby improving therapeutic outcomes.
There are numerous opportunities in this market, particularly in the implementation of personalized medicine approaches and digital health technologies. The integration of drug delivery devices with mobile health applications and wearables offers a valuable opportunity to actively engage patients in their treatment plans and therapy adherence. Additionally, partnerships between pharmaceutical companies and medical device manufacturers can result in innovative solutions that optimize therapy regimens and address specific patient requirements. In recent years, there has been a trend toward the use of injectable drug delivery systems, particularly those that can deliver longer-lasting effects and reduce the frequency of administration.
Global markets are experiencing an increase in the approval and adoption of novel delivery systems as regulatory frameworks continue to adapt to accommodate the introduction of these innovative devices. Additionally, there is a growing emphasis on sustainability in the development of drug delivery devices, as manufacturers seek to reduce their environmental impact by utilizing eco-friendly materials and practices. In general, the Drug Delivery Devices Market is on a positive trajectory, influenced by the demand for more effective patient engagement strategies, the increasing demand for healthcare, and advancements in technology.
This changing landscape is a critical area for investment and research that has the potential to substantially impact global health outcomes.
<p>The ongoing evolution of drug delivery devices appears to be driven by advancements in technology and a growing emphasis on patient-centric solutions, suggesting a transformative shift in the healthcare landscape.</p>
U.S. Food and Drug Administration (FDA)
Drug Delivery Devices Market Market Drivers
Market Growth Projections
The Global Drug Delivery Devices Market Industry is projected to experience substantial growth in the coming years. With a market value of 48.1 USD Billion in 2024, it is expected to reach 85.4 USD Billion by 2035, reflecting a robust CAGR of 5.35% from 2025 to 2035. This growth trajectory indicates a rising demand for innovative drug delivery solutions across various therapeutic areas. Factors such as technological advancements, increasing chronic disease prevalence, and supportive regulatory frameworks are likely to contribute to this upward trend. The market's expansion presents opportunities for stakeholders to invest in and develop cutting-edge drug delivery devices.
Technological Advancements
The Global Drug Delivery Devices Market Industry is experiencing rapid growth due to ongoing technological advancements. Innovations such as smart inhalers, wearable drug delivery systems, and implantable devices are enhancing patient compliance and therapeutic outcomes. For instance, the integration of digital health technologies allows for real-time monitoring and data collection, which can significantly improve treatment efficacy. As a result, the market is projected to reach 48.1 USD Billion in 2024, reflecting a strong demand for more efficient delivery mechanisms. These advancements not only facilitate better disease management but also contribute to the overall expansion of the industry.
Growing Geriatric Population
The aging population globally is contributing to the expansion of the Global Drug Delivery Devices Market Industry. As individuals age, they often experience multiple health issues that require complex medication regimens. Drug delivery devices that simplify administration, such as pre-filled syringes and auto-injectors, are becoming increasingly vital. The geriatric demographic is projected to grow significantly in the coming years, necessitating tailored drug delivery solutions that accommodate their unique health requirements. This trend is expected to bolster market growth, as healthcare providers seek efficient ways to manage the health of older adults.
Increased Investment in Healthcare
Investment in healthcare infrastructure is a significant factor propelling the Global Drug Delivery Devices Market Industry. Governments and private sectors are allocating substantial resources to enhance healthcare services, particularly in developing regions. This influx of capital is directed towards the development and distribution of advanced drug delivery systems, which are essential for effective treatment protocols. Enhanced funding facilitates research and development initiatives, leading to the introduction of novel devices that cater to diverse patient needs. As healthcare systems evolve, the demand for sophisticated drug delivery solutions is likely to rise, further driving market growth.
Regulatory Support and Initiatives
Regulatory bodies worldwide are increasingly supporting the development of innovative drug delivery devices, which is positively impacting the Global Drug Delivery Devices Market Industry. Initiatives aimed at expediting the approval process for new devices encourage manufacturers to invest in research and development. For instance, the introduction of streamlined regulatory pathways for novel drug delivery systems allows for quicker market entry, fostering competition and innovation. This supportive regulatory environment not only enhances the availability of advanced devices but also contributes to the overall growth of the market, as companies are motivated to bring their innovations to fruition.
Rising Prevalence of Chronic Diseases
The increasing incidence of chronic diseases worldwide is a major driver for the Global Drug Delivery Devices Market Industry. Conditions such as diabetes, cardiovascular diseases, and cancer necessitate effective drug delivery solutions to manage symptoms and improve patient quality of life. For example, the growing number of diabetes patients has led to a surge in demand for insulin delivery devices. This trend is expected to continue, with the market anticipated to grow at a CAGR of 5.35% from 2025 to 2035, ultimately reaching 85.4 USD Billion by 2035. The urgent need for innovative delivery systems to address these health challenges underscores the industry's potential.
Market Segment Insights
Drug Delivery Devices Market Drug Delivery Route Insights
<p>The Drug Delivery Route segment of the Drug Delivery Devices Market is pivotal, showing a promising path forward. In 2024, the market reached a valuation of 48.14 USD Billion, with the entire market expected to grow significantly by 2035, achieving a value of 85.4 USD Billion. This segment includes various routes through which drugs are delivered, such as Oral, Injectable, Transdermal, Inhalation, and Implantable, each playing a crucial role in therapy management among patients across the globe.</p>
<p>The Oral drug delivery route holds the largest market share, valued at 15.0 USD Billion in 2024 and projected to double to 28.5 USD Billion by 2035, due to its simplicity and patient compliance.This route is preferable for many patients as it offers ease of administration and a non-invasive approach. Injectables follow closely, valued at 18.0 USD Billion in 2024 and estimated to reach 31.0 USD Billion by 2035. This method is essential for delivering biologics and vaccines, showcasing its importance in the current healthcare landscape, especially in managing chronic conditions.</p>
<p>Transdermal delivery, valued at 6.0 USD Billion in 2024 and projected to rise to 10.5 USD Billion in 2035, provides another significant pathway as it ensures steady plasma levels, minimizing gastrointestinal issues often associated with oral medications.The Inhalation route, valued at 5.0 USD Billion in 2024, is critical for treating respiratory conditions, offering rapid absorption and minimizing systemic side effects, with projected growth leading to a value of 8.0 USD Billion by 2035.</p>
Drug Delivery Devices Market Device Type Insights
<p>The Device Type segment of the Drug Delivery Devices Market plays a critical role in shaping the industry landscape. In 2024, this market was valued at 48.14 USD Billion, reflecting its growth and significance. Among the various types of delivery devices, syringes and pumps are prominent due to their widespread use in administering medications accurately. Inhalers and nebulizers are vital, particularly for patients with respiratory conditions, as they enable effective delivery of therapeutic agents directly to the lungs.</p>
<p>Patch delivery systems have gained traction owing to their convenience and ease of use, appealing to patients seeking non-intrusive options.The Drug Delivery Devices Market data indicates that these devices are evolving with technological advancements, focusing on smart and connected devices that enhance patient adherence and outcomes. Market growth is further driven by increasing chronic diseases and a growing emphasis on home healthcare. The Drug Delivery Devices Market segmentation reflects the diverse needs of patients and healthcare providers, highlighting the importance of innovation in this space to improve treatment efficacy and patient quality of life.</p>
Drug Delivery Devices Market Application Insights
<p>The Drug Delivery Devices Market exhibits substantial growth across various applications, contributing to its projected valuation of 48.14 USD Billion in 2024. The market is marked by a significant focus on applications such as Diabetes, Cancer, Cardiovascular issues, Autoimmune Disorders, and Pain Management, reflecting the increasing need for effective therapeutic solutions. The Diabetes segment is particularly vital, as the rise in diabetes prevalence globally drives innovations in insulin delivery devices.</p>
<p>Cancer treatment technologies are also emerging as a major area of innovation, enabling targeted therapies that enhance treatment efficacy.Similarly, the importance of drug delivery systems in Cardiovascular health cannot be understated, as advancements in these tools help manage and treat heart-related conditions more effectively. Autoimmune Disorders are another critical area, with increasing demand for precision drug delivery mechanisms to cater to diverse patient needs. Additionally, Pain Management solutions are gaining prominence, with patients seeking more effective and user-friendly delivery methods.</p>
<p>Overall, the diverse applications within the Drug Delivery Devices Market reflect the industry's response to varying health challenges, driving market growth and contributing to ongoing improvements in patient care and treatment outcomes.</p>
Drug Delivery Devices Market End User Insights
<p>The Drug Delivery Devices Market is witnessing significant growth across various End User segments, driven by the increasing demand for innovative healthcare solutions. In 2024, the market reached a valuation of 48.14 billion USD, with hospitals representing a dominant share due to their essential role in patient care and acute treatment capabilities. Homecare services have also become vital as patients increasingly prefer receiving care in comfort, accelerating the adoption of drug delivery systems tailored for home use.</p>
<p>Pharmaceutical companies play a crucial role in this sector, as they develop and produce advanced drug delivery technologies, significantly influencing market trends.Research Institutions are pivotal for driving innovations in drug delivery mechanisms, focusing on improving efficacy and patient compliance. Overall, the Drug Delivery Devices Market data showcases a strong correlation between technological advancements and the rising expectations from various End Users, contributing to an expected market growth trajectory that highlights opportunities for improved healthcare delivery. As trends evolve, understanding the Drug Delivery Devices Market segmentation will be critical for stakeholders looking to navigate the complexities of this dynamic industry.</p>
Get more detailed insights about Drug Delivery Devices Market Research Report—Global Forecast till 2035
Regional Insights
The Drug Delivery Devices Market is projected to experience significant growth across various regions, contributing to an overall valuation of 48.14 USD Billion in 2024. North America led the regional landscape with a value of 18.0 USD Billion, expected to rise to 32.0 USD Billion by 2035, largely driven by advanced healthcare infrastructure and increasing adoption of innovative drug delivery solutions.
Europe is also a vital player, valued at 14.0 USD Billion in 2024, with a forecasted increase to 24.0 USD Billion, reflecting a robust market due to high demand for sophisticated medical devices.In South America, the market was valued at 3.5 USD Billion in 2024, progressing to 6.0 USD Billion, showcasing development opportunities amid a growing healthcare sector. The Asia Pacific region reported a valuation of 10.5 USD Billion for 2024, anticipated to reach 18.0 USD Billion, driven by rising population and increasing investments in healthcare technologies.
Lastly, the Middle East and Africa, valued at 2.14 USD Billion in 2024, is expected to grow to 5.4 USD Billion, indicating a developing market with high potential. Each region plays a crucial role in shaping the Drug Delivery Devices Market statistics, reflecting varying demands, technological advancements, and healthcare challenges, thereby influencing market growth dynamics.
Key Players and Competitive Insights
The Drug Delivery Devices Market is characterized by rapid technological advancements, evolving patient preferences, and a growing emphasis on personalized medicine. Within this competitive landscape, manufacturers and service providers are increasingly focusing on innovation, regulatory compliance, and strategic partnerships to enhance their product offerings and market reach. The demand for efficient drug delivery systems that ensure accuracy, improve patient adherence, and minimize adverse effects has propelled growth in this market.
Companies are leveraging advancements in materials science, microfabrication techniques, and digital technologies to create a diverse range of drug delivery devices, which span from traditional syringes and inhalers to sophisticated smart devices and implantable systems. The competitive environment is further intensified by the presence of key players, emerging companies, and collaborations aimed at addressing unmet medical needs and addressing the unique demands of various therapeutic areas.Becton Dickinson operates prominently within the Drug Delivery Devices Market, standing out for its comprehensive product portfolio that includes innovative solutions for medication delivery across various therapeutic areas.
The company's strengths lie in its robust research and development capabilities, which enable the introduction of cutting-edge technologies that enhance the efficiency and safety of drug administration. With a strong global presence and a commitment to quality and regulatory compliance, Becton Dickinson effectively positions itself to meet the evolving needs of healthcare providers and patients alike.
Its established distribution network and strong brand reputation further contribute to its competitive advantage, allowing the company to maintain market leadership and explore new growth opportunities in emerging markets.Merck is a significant player in the Drug Delivery Devices Market, offering a range of products and services designed to facilitate effective drug administration across multiple therapeutic areas. With a strategic focus on delivering innovative solutions, Merck ensures its drug delivery systems are aligned with cutting-edge research and emerging healthcare trends.
The firm has capitalized on its strengths in biotechnology and a deep understanding of patient needs to develop user-friendly and efficient drug delivery mechanisms. Merck's global footprint, supported by strategic mergers and acquisitions, enhances its ability to compete in various markets, allowing it to diversify its portfolio and bolster its presence. The company maintains strong collaborations with healthcare professionals and stakeholders, ensuring its products are relevant and effective for end-users, reflecting its commitment to advancing healthcare through innovation and integration of technology.
Key Companies in the Drug Delivery Devices Market market include
Industry Developments
The Drug Delivery Devices Market has witnessed significant developments recently, particularly driven by advancements in technology and increasing demand for effective treatment solutions
Thermo Fisher Scientific and AstraZeneca did not disclose a strategic partnership that was specifically designed to address drug delivery systems in October 2023. While both organizations persist in their pursuit of innovation—AstraZeneca in biologics delivery and Thermo Fisher in manufacturing and productivity tools—there is no documentation of a formal partnership that was established in that month to improve drug delivery technologies.An acquisition of a novel drug delivery technology firm was not completed by Merck in September 2023. In April 2024, Merck acquired Abceutics, a preclinical startup that specializes in payload-binding selectivity enhancers for antibody-drug conjugates, for up to $208 million.
The objective of this acquisition was to enhance the safety of ADCs. Nevertheless, Merck has continued to be active in drug delivery innovation. Merck's oncology pipeline was reinforced by the acquisition of Harpoon Therapeutics for approximately $680 million in January 2024. This acquisition included innovative T-cell engager technologies.
Future Outlook
Drug Delivery Devices Market Future Outlook
<p>The Global Drug Delivery Devices Market is projected to grow at a 4.90% CAGR from 2025 to 2035, driven by technological advancements, increasing chronic diseases, and demand for patient-centric solutions.</p>
New opportunities lie in:
- <p>Invest in smart delivery systems integrating IoT for real-time monitoring and patient adherence. Develop biodegradable drug delivery devices to meet sustainability demands and regulatory requirements. Explore partnerships with biotech firms to enhance drug formulation and delivery efficiency.</p>
<p>By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.</p>
Market Segmentation
Drug Delivery Devices Market End User Outlook
- Hospitals
- Homecare
- Pharmaceutical Companies
- Research Institutions
Drug Delivery Devices Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
Drug Delivery Devices Market Application Outlook
- Diabetes
- Cancer
- Cardiovascular
- Autoimmune Disorders
- Pain Management
Drug Delivery Devices Market Device Type Outlook
- Syringes
- Pumps
- Inhalers
- Patch Delivery Systems
- Nebulizers
Drug Delivery Devices Market Drug Delivery Route Outlook
- Oral
- Injectable
- Transdermal
- Inhalation
- Implantable
Report Scope
| Report Attribute/Metric | Details |
| Market Size 2024 | 48.14 (USD Billion) |
| Market Size 2035 | 468.65 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 4.90% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Becton Dickinson, Merck, Thermo Fisher Scientific, Syringe Solutions, Smiths Medical, GlaxoSmithKline, AstraZeneca, Medtronic, Philips, Teva Pharmaceuticals, 3M, Johnson & Johnson, Roche, Novo Nordisk, AbbVie |
| Segments Covered | Drug Delivery Route, Device Type, Application, End User, Regional |
| Key Market Opportunities | Wearable drug delivery systems, Enhanced patient adherence solutions, Digital integration in devices, Personalized medicine advancement, Expansion in emerging markets. |
| Key Market Dynamics | Rising demand for personalized medicine, Technological advancements in drug delivery, Increasing prevalence of chronic diseases, Growth in self-administration devices, Expanding biotechnology and biosimilar markets |
| Countries Covered | North America, Europe, APAC, South America, MEA |
| Market Size 2025 | 290.41 (USD Billion) |
Market Highlights
Author
Latest Comments
John Doe
john@example.com
This is a great article! Really helped me understand the topic better.
Posted on July 23, 2025, 10:15
AM
Jane Smith
jane@domain.com
Thanks for sharing this. I’ve bookmarked it for later reference.
Posted on July 22, 2025, 7:45
PM
FAQs
What was the projected market size of the Drug Delivery Devices Market in 2024?
The market was valued at 48.14 USD Billion in 2024.
What is the predicted market size for the Drug Delivery Devices Market by 2035?
By 2035, the market is anticipated to reach a size of 85.4 USD Billion.
What is the expected compound annual growth rate (CAGR) for the Drug Delivery Devices Market between 2025 and 2035?
The expected CAGR for this period is 5.35%.
Which region held the largest market share for the Drug Delivery Devices Market in 2024?
In 2024, North America have the largest market share, valued at 18.0 USD Billion.
How much is the European market for Drug Delivery Devices projected to be in 2035?
The market in Europe is projected to grow to 24.0 USD Billion by 2035.
What is the forecasted market value for the injectable segment of the Drug Delivery Devices Market by 2035?
The injectable segment is expected to reach a value of 31.0 USD Billion by 2035.
Who are the major players in the Drug Delivery Devices Market?
Key players include Becton Dickinson, Merck, Thermo Fisher Scientific, and Johnson & Johnson, among others.
What was the market size for oral drug delivery segment in 2024?
The oral drug delivery segment was valued at 15.0 USD Billion in 2024.
What are the market expectations for Asia Pacific by 2035?
The market in Asia Pacific is projected to reach 18.0 USD Billion by 2035.
What challenges and opportunities exist in the Drug Delivery Devices Market?
Emerging trends, advancements in technology, and increasing demand for safer delivery methods present both challenges and opportunities.
-
--- "
-
Table of Contents
-
EXECUTIVE SUMMARY
-
Market Overview
-
Key Findings
-
Market Segmentation
-
Competitive Landscape
-
Challenges and Opportunities
-
Future Outlook
-
MARKET INTRODUCTION
-
Definition
-
Scope of the study
-
Research Objective
-
Assumption
-
Limitations
-
RESEARCH METHODOLOGY
-
Overview
-
Data Mining
-
Secondary Research
-
Primary Research
-
Primary Interviews and Information Gathering Process
-
Breakdown of Primary Respondents
-
Forecasting Model
-
Market Size Estimation
-
Bottom-Up Approach
-
Top-Down Approach
-
Data Triangulation
-
Validation
-
MARKET DYNAMICS
-
Overview
-
Drivers
-
Restraints
-
Opportunities
-
MARKET FACTOR ANALYSIS
-
Value chain Analysis
-
Porter's Five Forces Analysis
-
Bargaining Power of Suppliers
-
Bargaining Power of Buyers
-
Threat of New Entrants
-
Threat of Substitutes
-
Intensity of Rivalry
-
COVID-19 Impact Analysis
-
Market Impact Analysis
-
Regional Impact
-
Opportunity and Threat Analysis
-
Drug Delivery Devices Market, BY Drug Delivery Route (USD Billion)
-
Oral
-
Injectable
-
Transdermal
-
Inhalation
-
Implantable
-
Drug Delivery Devices Market, BY Device Type (USD Billion)
-
Syringes
-
Pumps
-
Inhalers
-
Patch Delivery Systems
-
Nebulizers
-
Drug Delivery Devices Market, BY Application (USD Billion)
-
Diabetes
-
Cancer
-
Cardiovascular
-
Autoimmune Disorders
-
Pain Management
-
Drug Delivery Devices Market, BY End User (USD Billion)
-
Hospitals
-
Homecare
-
Pharmaceutical Companies
-
Research Institutions
-
Drug Delivery Devices Market, BY Regional (USD Billion)
-
North America
-
US
-
Canada
-
Europe
-
Germany
-
UK
-
France
-
Russia
-
Italy
-
Spain
-
Rest of Europe
-
APAC
-
China
-
India
-
Japan
-
South Korea
-
Malaysia
-
Thailand
-
Indonesia
-
Rest of APAC
-
South America
-
Brazil
-
Mexico
-
Argentina
-
Rest of South America
-
MEA
-
GCC Countries
-
South Africa
-
Rest of MEA
-
Competitive Landscape
-
Overview
-
Competitive Analysis
-
Market share Analysis
-
Major Growth Strategy in the Drug Delivery Devices Market
-
Competitive Benchmarking
-
Leading Players in Terms of Number of Developments in the Drug Delivery Devices Market
-
Key developments and growth strategies
-
New Product Launch/Service Deployment
-
Merger & Acquisitions
-
Joint Ventures
-
Major Players Financial Matrix
-
Sales and Operating Income
-
Major Players R&D Expenditure. 2023
-
Company Profiles
-
Pfizer
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Merck and Co
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Sandoz
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
AbbVie
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Roche
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Eli Lilly
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Boehringer Ingelheim
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Johnson and Johnson
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Novartis
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Hikma Pharmaceuticals
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Medtronic
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Becton Dickinson
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
AstraZeneca
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
GlaxoSmithKline
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Sanofi
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Appendix
-
References
-
Related Reports
Drug Delivery Devices Market Segmentation
Drug Delivery Devices Market By Drug Delivery Route (USD Billion, 2019-2035)
Oral
Injectable
Transdermal
Inhalation
Implantable
Drug Delivery Devices Market By Device Type (USD Billion, 2019-2035)
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
Drug Delivery Devices Market By Application (USD Billion, 2019-2035)
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
Drug Delivery Devices Market By End User (USD Billion, 2019-2035)
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
Drug Delivery Devices Market By Regional (USD Billion, 2019-2035)
North America
Europe
South America
Asia Pacific
Middle East and Africa
Drug Delivery Devices Market Regional Outlook (USD Billion, 2019-2035)
North America Outlook (USD Billion, 2019-2035)
North America Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
North America Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
North America Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
North America Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
North America Drug Delivery Devices Market by Regional Type
US
Canada
US Outlook (USD Billion, 2019-2035)
US Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
US Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
US Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
US Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
CANADA Outlook (USD Billion, 2019-2035)
CANADA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
CANADA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
CANADA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
CANADA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
Europe Outlook (USD Billion, 2019-2035)
Europe Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
Europe Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
Europe Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
Europe Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
Europe Drug Delivery Devices Market by Regional Type
Germany
UK
France
Russia
Italy
Spain
Rest of Europe
GERMANY Outlook (USD Billion, 2019-2035)
GERMANY Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
GERMANY Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
GERMANY Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
GERMANY Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
UK Outlook (USD Billion, 2019-2035)
UK Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
UK Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
UK Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
UK Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
FRANCE Outlook (USD Billion, 2019-2035)
FRANCE Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
FRANCE Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
FRANCE Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
FRANCE Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
RUSSIA Outlook (USD Billion, 2019-2035)
RUSSIA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
RUSSIA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
RUSSIA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
RUSSIA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
ITALY Outlook (USD Billion, 2019-2035)
ITALY Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
ITALY Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
ITALY Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
ITALY Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
SPAIN Outlook (USD Billion, 2019-2035)
SPAIN Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
SPAIN Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
SPAIN Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
SPAIN Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
REST OF EUROPE Outlook (USD Billion, 2019-2035)
REST OF EUROPE Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
REST OF EUROPE Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
REST OF EUROPE Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
REST OF EUROPE Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
APAC Outlook (USD Billion, 2019-2035)
APAC Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
APAC Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
APAC Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
APAC Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
APAC Drug Delivery Devices Market by Regional Type
China
India
Japan
South Korea
Malaysia
Thailand
Indonesia
Rest of APAC
CHINA Outlook (USD Billion, 2019-2035)
CHINA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
CHINA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
CHINA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
CHINA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
INDIA Outlook (USD Billion, 2019-2035)
INDIA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
INDIA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
INDIA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
INDIA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
JAPAN Outlook (USD Billion, 2019-2035)
JAPAN Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
JAPAN Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
JAPAN Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
JAPAN Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
SOUTH KOREA Outlook (USD Billion, 2019-2035)
SOUTH KOREA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
SOUTH KOREA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
SOUTH KOREA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
SOUTH KOREA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
MALAYSIA Outlook (USD Billion, 2019-2035)
MALAYSIA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
MALAYSIA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
MALAYSIA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
MALAYSIA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
THAILAND Outlook (USD Billion, 2019-2035)
THAILAND Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
THAILAND Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
THAILAND Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
THAILAND Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
INDONESIA Outlook (USD Billion, 2019-2035)
INDONESIA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
INDONESIA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
INDONESIA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
INDONESIA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
REST OF APAC Outlook (USD Billion, 2019-2035)
REST OF APAC Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
REST OF APAC Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
REST OF APAC Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
REST OF APAC Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
South America Outlook (USD Billion, 2019-2035)
South America Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
South America Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
South America Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
South America Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
South America Drug Delivery Devices Market by Regional Type
Brazil
Mexico
Argentina
Rest of South America
BRAZIL Outlook (USD Billion, 2019-2035)
BRAZIL Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
BRAZIL Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
BRAZIL Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
BRAZIL Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
MEXICO Outlook (USD Billion, 2019-2035)
MEXICO Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
MEXICO Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
MEXICO Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
MEXICO Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
ARGENTINA Outlook (USD Billion, 2019-2035)
ARGENTINA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
ARGENTINA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
ARGENTINA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
ARGENTINA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
REST OF SOUTH AMERICA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
REST OF SOUTH AMERICA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
REST OF SOUTH AMERICA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
REST OF SOUTH AMERICA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
MEA Outlook (USD Billion, 2019-2035)
MEA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
MEA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
MEA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
MEA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
MEA Drug Delivery Devices Market by Regional Type
GCC Countries
South Africa
Rest of MEA
GCC COUNTRIES Outlook (USD Billion, 2019-2035)
GCC COUNTRIES Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
GCC COUNTRIES Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
GCC COUNTRIES Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
GCC COUNTRIES Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
SOUTH AFRICA Outlook (USD Billion, 2019-2035)
SOUTH AFRICA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
SOUTH AFRICA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
SOUTH AFRICA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
SOUTH AFRICA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
REST OF MEA Outlook (USD Billion, 2019-2035)
REST OF MEA Drug Delivery Devices Market by Drug Delivery Route Type
Oral
Injectable
Transdermal
Inhalation
Implantable
REST OF MEA Drug Delivery Devices Market by Device Type
Syringes
Pumps
Inhalers
Patch Delivery Systems
Nebulizers
REST OF MEA Drug Delivery Devices Market by Application Type
Diabetes
Cancer
Cardiovascular
Autoimmune Disorders
Pain Management
REST OF MEA Drug Delivery Devices Market by End User Type
Hospitals
Homecare
Pharmaceutical Companies
Research Institutions
Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment